COPENHAGEN, Denmark, December 18, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Board of Directors has decided to establish a long-term incentive program for Executive Management as ...

The Board of Directors of BW Energy Limited ("BWE" or the "Company") approved the award of share options under a Long-Term Incentive Program (LTIP) to align the interests of the participating ...

WARREN, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that the current time- and individual performance-based long-term ...

Zealand Pharma has implemented the LTIP to align with selected European and U.S. biotech peers, with the program designed to drive long-term value creation, align the interests of Corporate Management ...

Members of Hydro’s Executive Leadership Team have received shares in Hydro via the Long-Term Incentive plan and purchased shares via the employee share purchase program. Long-Term Incentive plan Norsk ...

HELLERUP, Denmark, April 11, 2025 /PRNewswire/ -- Following exercise of 365,096 original RSUs granted in the 2022 Long Term Incentive Program and the 2023 Retention Program, the Board of Directors has ...

In accordance with the guidelines for remuneration and other terms of employment for key executives (the "Guidelines") approved at the Annual General Meeting on 22 April 2026, the board of directors o ...

Copenhagen, Denmark, April 19, 2025 – Zealand Pharma A/S ("the Company" or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company focused on the discovery and development of ...

Zealand Pharma launches long-term incentive programs for Zealand Pharma’s Board of Directors, Corporate Management and employees for 2026 Copenhagen, Denmark, April 19, 2026 – Zealand Pharma A/S ("the ...